FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2578570244> ?p ?o ?g. }

• W2578570244 endingPage "498" @default.
• W2578570244 startingPage "493" @default.
• W2578570244 abstract "Nevirapine (NVP)-based combination antiretroviral therapy is routinely prescribed to infants deemed at high risk of vertical HIV infection in our centers. We evaluated NVP pharmacokinetics and safety of this regimen.Neonates were recruited prospectively between September 2012 and April 2015 or enrolled retrospectively if treated similarly before prospective study initiation. NVP was dosed at 150 mg/m daily for 14 days, then twice daily for 14 days. NVP levels were drawn at weeks 1, 2, and 4 [target trough (NVP-T): 3-8 mg/L].Thirty-three neonates were included (23 prospectively). Median gestational age (GA) and birth weight were 38 weeks (32-41 weeks) and 2.9 kg (1.5-4.2 kg), respectively. Median NVP-Ts were 8.2 mg/L (1.6-25.1 mg/L), 3.5 mg/L (1.6-6.8 mg/L), and 4.3 mg/L (0.1-19.9 mg/L) at weeks 1, 2, and 4, respectively. The proportions with therapeutic NVP-T were 42%, 61%, and 73% at these same timepoints. Median apparent oral clearance (CL/F) increased from 0.05 L·kg·h (0.01-0.50 L·kg·h) at week 2 to 0.18 L·kg·h (0.01-0.78 L·kg·h) at week 4. Increased drug exposure [area under the curve (AUCτ)] correlated with younger GA (r = 0.459, P = 0.032) and lower birth weight (r = 0.542, P = 0.009). The most common adverse events potentially attributable to combination antiretroviral therapy were transient asymptomatic hyperlactatemia (26%), anemia (24.7%), and neutropenia (22.1%).Treatment dose NVP was generally well-tolerated and associated with normalization of trough levels over time in most cases without dose adjustment. Lower empiric dosing is recommended for infants <34 weeks of GA. Routine therapeutic drug monitoring may not be required for infants ≥34 weeks of GA." @default.
• W2578570244 created "2017-01-26" @default.
• W2578570244 creator A5005290245 @default.
• W2578570244 creator A5008109335 @default.
• W2578570244 creator A5012297869 @default.
• W2578570244 creator A5028740151 @default.
• W2578570244 creator A5063258902 @default.
• W2578570244 creator A5068163031 @default.
• W2578570244 creator A5076991437 @default.
• W2578570244 creator A5080324507 @default.
• W2578570244 creator A5084468526 @default.
• W2578570244 creator A5085361999 @default.
• W2578570244 creator A5091191553 @default.
• W2578570244 date "2017-04-15" @default.
• W2578570244 modified "2023-10-02" @default.
• W2578570244 title "Nevirapine Pharmacokinetics and Safety in Neonates Receiving Combination Antiretroviral Therapy for Prevention of Vertical HIV Transmission" @default.
• W2578570244 cites W1953234161 @default.
• W2578570244 cites W1967503024 @default.
• W2578570244 cites W1971424423 @default.
• W2578570244 cites W1977000190 @default.
• W2578570244 cites W2052049408 @default.
• W2578570244 cites W2061673014 @default.
• W2578570244 cites W2067788204 @default.
• W2578570244 cites W2075643141 @default.
• W2578570244 cites W2119181700 @default.
• W2578570244 cites W2120255324 @default.
• W2578570244 cites W2122527560 @default.
• W2578570244 cites W2122846238 @default.
• W2578570244 cites W2155050390 @default.
• W2578570244 cites W2163511888 @default.
• W2578570244 cites W2266022411 @default.
• W2578570244 cites W2292125503 @default.
• W2578570244 cites W2329154031 @default.
• W2578570244 cites W4297851374 @default.
• W2578570244 doi "https://doi.org/10.1097/qai.0000000000001291" @default.
• W2578570244 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28114187" @default.
• W2578570244 hasPublicationYear "2017" @default.
• W2578570244 type Work @default.
• W2578570244 sameAs 2578570244 @default.
• W2578570244 citedByCount "13" @default.
• W2578570244 countsByYear W25785702442016 @default.
• W2578570244 countsByYear W25785702442019 @default.
• W2578570244 countsByYear W25785702442021 @default.
• W2578570244 countsByYear W25785702442022 @default.
• W2578570244 crossrefType "journal-article" @default.
• W2578570244 hasAuthorship W2578570244A5005290245 @default.
• W2578570244 hasAuthorship W2578570244A5008109335 @default.
• W2578570244 hasAuthorship W2578570244A5012297869 @default.
• W2578570244 hasAuthorship W2578570244A5028740151 @default.
• W2578570244 hasAuthorship W2578570244A5063258902 @default.
• W2578570244 hasAuthorship W2578570244A5068163031 @default.
• W2578570244 hasAuthorship W2578570244A5076991437 @default.
• W2578570244 hasAuthorship W2578570244A5080324507 @default.
• W2578570244 hasAuthorship W2578570244A5084468526 @default.
• W2578570244 hasAuthorship W2578570244A5085361999 @default.
• W2578570244 hasAuthorship W2578570244A5091191553 @default.
• W2578570244 hasConcept C112705442 @default.
• W2578570244 hasConcept C126322002 @default.
• W2578570244 hasConcept C142462285 @default.
• W2578570244 hasConcept C188816634 @default.
• W2578570244 hasConcept C197934379 @default.
• W2578570244 hasConcept C203014093 @default.
• W2578570244 hasConcept C2778376644 @default.
• W2578570244 hasConcept C2779130552 @default.
• W2578570244 hasConcept C2779234561 @default.
• W2578570244 hasConcept C2781413609 @default.
• W2578570244 hasConcept C2910800852 @default.
• W2578570244 hasConcept C2993143319 @default.
• W2578570244 hasConcept C3013748606 @default.
• W2578570244 hasConcept C54355233 @default.
• W2578570244 hasConcept C66322754 @default.
• W2578570244 hasConcept C71924100 @default.
• W2578570244 hasConcept C86803240 @default.
• W2578570244 hasConcept C90924648 @default.
• W2578570244 hasConceptScore W2578570244C112705442 @default.
• W2578570244 hasConceptScore W2578570244C126322002 @default.
• W2578570244 hasConceptScore W2578570244C142462285 @default.
• W2578570244 hasConceptScore W2578570244C188816634 @default.
• W2578570244 hasConceptScore W2578570244C197934379 @default.
• W2578570244 hasConceptScore W2578570244C203014093 @default.
• W2578570244 hasConceptScore W2578570244C2778376644 @default.
• W2578570244 hasConceptScore W2578570244C2779130552 @default.
• W2578570244 hasConceptScore W2578570244C2779234561 @default.
• W2578570244 hasConceptScore W2578570244C2781413609 @default.
• W2578570244 hasConceptScore W2578570244C2910800852 @default.
• W2578570244 hasConceptScore W2578570244C2993143319 @default.
• W2578570244 hasConceptScore W2578570244C3013748606 @default.
• W2578570244 hasConceptScore W2578570244C54355233 @default.
• W2578570244 hasConceptScore W2578570244C66322754 @default.
• W2578570244 hasConceptScore W2578570244C71924100 @default.
• W2578570244 hasConceptScore W2578570244C86803240 @default.
• W2578570244 hasConceptScore W2578570244C90924648 @default.
• W2578570244 hasIssue "5" @default.
• W2578570244 hasLocation W25785702441 @default.
• W2578570244 hasLocation W25785702442 @default.
• W2578570244 hasOpenAccess W2578570244 @default.
• W2578570244 hasPrimaryLocation W25785702441 @default.
• W2578570244 hasRelatedWork W2011720238 @default.

• next